United States Biotechnology & Medical Research

Aeon Biopharma Inc (AEON)

Aeon Biopharma recorded one significant insider purchase during the past ninety days. Timothy P. Lynch acquired shares valued at approximately 243,455 USD on August 19, 2026. This activity follows a recent earnings report where the firm exceeded expectations. The stock price has declined 36.5 percent over the last quarter, currently trading near its yearly low.
Ticker: AEON Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Aeon Biopharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
LYNCH TIMOTHY P Large shareholder
Transaction date
Purchase
Price
239.61
Quantity 31,754 -40.0%
Value US$683,723
3.6
FISCHER JOST Non-Executive Director
Transaction date
Purchase
Price
327.37
Quantity 72,978 +30.0%
Value US$2,187,786
3.6
FISCHER JOST Non-Executive Director
Transaction date
Purchase
Price
271.18
Quantity 31,590 +21.8%
Value US$3,982,220
3.6
FISCHER JOST Non-Executive Director
Transaction date
Purchase
Price
0.50
Quantity 50,000 +51.7%
Value US$24,940
Oleg Grodnensky Affiliate
Transaction date
Proposed sale
Price
2.63
Quantity 201,825
Value US$530,780
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-21 2026-08-19 B Purchase
LYNCH TIMOTHY P
Large shareholder
31,754 -40.0%
239.61
US$683,723 		31,754 -40.0% 239.61 US$683,723
2025-05-23 2025-05-21 B Purchase
3.6
FISCHER JOST
Non-Executive Director
72,978 +30.0%
327.37
US$2,187,786 		72,978 +30.0% 327.37 US$2,187,786
2025-05-21 2025-05-20 B Purchase
3.6
FISCHER JOST
Non-Executive Director
31,590 +21.8%
271.18
US$3,982,220 		31,590 +21.8% 271.18 US$3,982,220
2025-05-21 2025-05-19 B Purchase
3.6
FISCHER JOST
Non-Executive Director
50,000 +51.7%
0.50
US$24,940 		50,000 +51.7% 0.50 US$24,940
2024-07-29 2024-07-29 PrS Proposed sale
Oleg Grodnensky

Affiliate
201,825
2.63
US$530,780 		201,825 2.63 US$530,780
Explore more

More insider trading research around Aeon Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America